Непосредственные результаты хирургического и эндоваскулярного лечения больных ишемической болезнью сердца: периоперационные осложнения, факторы риска, прогноз
Download
2. Какучая, Т. Т. Фибрилляция предсердий после АКШ: прогностические факторы, особенности диагностики и лечения: дис. … канд. мед. наук / Т. Т. Какучая. – М., 2004.
3. Лобачева, Г. В. Факторы риска развития после- операционных осложнений после операций на открытом сердце: дис. … д-ра мед. наук / Г. В. Лобачева. – М., 2000.
4. Фарафонова, Т. Н. Нарушения ритма сердца в ранние сроки после операции коронарного шунтирования на работающем сердце: дис. … канд. мед. наук / Т. Н. Фарафонова. – М., 2006.
5. Шумков, К. В. Сочетанное немедикаментозное лечение желудочковых аритмий у больных ИБС: дис. … канд. мед. наук / К. В. Шумков. – М., 2005.
6. Barner, H. B. Operative treatment of coronary atherosclerosis / H. B. Barner // Ann. Thorac. Surg. – 2008. – Vol. 85. – P. 1473–1482.
7. Bittl, J. A. Advances in coronary angioplasty / J. A. Bittl // N. Engl. J. Med. – 1996. – Vol. 335. – P. 1290–1302.
8. Booth, J. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS) / J. Booth, T. Clayton, J. Pepper et al. // Circulation. – 2008. – Vol. 118. – P. 381–388.
9. Bravata, D. M. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery / D. M. Bravata, A. L. Gienger, K. M. McDonald et al. // Ann. Intern. Med. – 2007. – Vol. 147. – P. 703–716.
10. Brener, S. J. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients / S. J. Brener, J. M. Galla, R. Bryant III et al. // Am. J. Cardiol. – 2008. – Vol. 101. – P. 169–172.
11. Briguori, C. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus / C. Briguori, G. Condorelli, F. Airoldi et al. // Am. J. Cardiol. – 2007. – Vol. 99. – P. 779–784.
12. Buszman, P. E. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization / P. E. Buszman, S. R. Kiesz, A. Bochenek et al. // J. Am. Coll. Cardiol. – 2008. – Vol. 51. – P. 538–545.
13. Buxton, B. F. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery: risk-adjusted survival / B. F. Buxton, M. Komeda, J. A. Fuller, I. Gordon // Circulation. – 1998. – Vol. 98 (Suppl. II-1).
14. Chieffo, A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience / A. Chieffo, N. Morici, F. Maisano et al. // Circulation. – 2006. – Vol. 113. – P. 2542–2547.
15. Cohen, D. Three-year SYNTAX results extend CABG advantage to intermediate-risk patients / D. Cohen, A. P. Kappetein. – 2010 // http://www.The heart.org
16. Colombo, A. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent / A. Colombo, J. Fajadet, G. Schuler // Eur. Heart J. – 2002. – Vol. 4. – P. 264 (Suppl. A).
17. Daemen, J. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials/ J. Daemen, E. Boersma, M. Flather et al. // Circulation. – 2008. – Vol. 118. – P. 1146–1154.
18. Fajadet, J. 210-day follow-up of the RAVEL Study: A randomized study with the sirolimus-eluting BX Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions / J. Fajadet, M. Perin, E. Hayashi // J. Am. Coll. Cardiol. – 2002. – Vol. 39. – P. 250 (Suppl. A).
19. Flynn, M. Fast-tracking revisited: routine cardiac surgical patients need minimal intensive care / M. Flynn, S. Reddy, W. Shepherd et al. // Eur. J. Cardiothorac. Surg. – 2004. – Vol. 25. – P. 116–122.
20. Grocott, H. P. Cognitive dysfunction after cardiac surgery: revisiting etiology / H. P. Grocott, H. M. Homi, F. Puskas // Semin. Cardiothorac. Vasc. Anesth. – 2005. – Vol. 9, № 2. – P. 123–129.
21. Grьntzig, A. Transluminal dilatation of coronaryartery stenosis / A. Grьntzig // Lancet. – 1978. – Vol. 1. – P. 263.
22. Hannan, E. L. Drug-eluting stents vs. coronaryartery bypass grafting in multivessel coronary disease / E. L. Hannan, C. Wu, G. Walford et al. // N. Engl. J. Med. – 2008. – Vol. 358. – P. 331–341.
23. Herz, I. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease / I. Herz, Y. Moshkovitz, D. Loberman et al. // Ann. Thorac. Surg. – 2005. – Vol. 80. – P. 2086–2090.
24. Holmes, D. R. Jr. Moses: Analysis of 1-year clinical outcomes in the SIRIUS trial / D. R. Holmes Jr, M. B. Leon // Circulation. – 2004. – Vol. 110, № 5. – P. 508–514.
25. Janssen, D. P. Preoperative prediction of prolonged stay in the intensive care unit for coronary bypass surgery / D. P. Janssen, L. Noyez, C. Wouters, R. M. Brouwer // Eur. J. Cardiothorac. Surg. – 2004. – Vol. 25. – P. 203–207.
26. Javaid, A. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease / A. Javaid, D. H. Steinberg, A. N. Buch et al. // Circulation. – 2007. – Vol. 116. – P. 200 (Suppl. 1).
27. Kaluza, G. L. Inhibition of restenosis with a paclitaxel- eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial / G. L. Kaluza, A. H. Gershlick // Am. J. Cardiol. – 2004. – Vol. 94, № 2. – P. 99–201.
28. Lagerqvist, B. Stent thrombosis in Sweden: a report from the Swedish coronary angiography and angioplasty registry / B. Lagerqvist, J. Carlsson, O. Frцbert et al. // Circ. Cardiovasc. Interv. – 2009. – Vol. 2. – P. 401–408.
29. Lee, M. S. Comparison of bypass surgery with drugeluting stents for diabetic patients with multivessel disease / M. S. Lee, F. Jamal, G. Kedia et al. // Int. J. Cardiol. – 2007. – Vol. 123. – P. 34–42.
30. Lee, M. S. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease / M. S. Lee, N. Kapoor, F. Jamal et al. // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – P. 864–870.
31. Lemos, P. A. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin – Eluting Stent Evaluation At Rotterdam Cardiology Hospital-(RESEARCH) registry / P. A. Lemos, C. H. Lee, M. Degertekin et al. // J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 2093–2099.
32. McKhann, G. M. Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction / G. M. McKhann, M. A. Grega, L. M. Borowicz Jr et al. // Arch. Neurol. – 2002. – Vol. 59, № 9. – P. 1422–1428.
33. Mora, Ch. T. The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patient undergoing coronar revascularization / Ch. T. Mora, M. B. Henson, W. S. Weintraub et al. // J. Thorac. Cardiovasc. Surg. – 1996. – Vol. 112. – P. 514–522.
34. Palmerini, T. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged >or=75 years) / T. Palmerini, F. Barlocco, A. Santarelli et al. // Eur. Heart J. – 2007. – Vol. 28. – P. 2714–2719.
35. Sanmartin, M. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease / M. Sanmartin, J. A. Baz, R. Claro et al. // Am. J. Cardiol. – 2007. – Vol. 100. – P. 970–973.
36. Schofer, J. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS) / J. Schofer, M. Schluter // Am. J. Ther. – 2004. – Vol. 11, № 3. – P. 218–228.
37. Serruys, P. W. Coronary-artery stents / P. W. Serruys, M. J. B. Kutryk, A. T. L. Ong // N. Engl. J. Med. – 2006. – Vol. 354. – P. 483–495.
38. Serruys, P. W. Percutaneous coronary intervention versus coronary artery bypass grafting for sever coronary artery disease / P. W. Serruys, M. C. Morice, A. P. Kappetein et al. // New Engl. J. Med. – 2009. – Vol. 360, № 10.
39. Serruys, P. W. Three-year follow-up of the ARTSII– sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease / P. W. Serruys, J. Daemen, M.-C. Morice et al. // EuroIntervention. – 2007. – Vol. 3. – P. 450–459.
40. Smith, S. C. Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) / S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr et al. // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – P. 216–235.
41. Stettler, C. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis / C. Stettler, S. Wandel, S. Allemann et al. // Lancet. – 2007. – Vol. 370. – P. 937–948.
42. Tavilla, G. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries / G. Tavilla, A. P. Kappetein, J. Braun et al. // Ann. Thorac. Surg. – 2004. – Vol. 77. – P. 794–799.
43. Wijns, W. ESC/EACTS Guidelines on myocardial revascularization 2010 / W. Wijns et al. // Eur. Heart J. – 2010. – Vol. 10, № 31. – P. 2501–2555.
44. Yang, Z. K. Coronary artery bypass surgery versus percutaneous coronary intervention with drugeluting stent implantation in patients with multivessel coronary disease / Z. K. Yang, W. F. Shen, R. Y. Zhang et al. // J. Interv. Cardiol. – 2007. – Vol. 20. – P. 10–16.
Abstract
The study was carried out in a group of 450 patients with ischemic heart disease (IHD) 29 to 80 years old (mean age 53.8 year old) after cardiac surgery. Patients were separated in two groups depending on the chosen method of myocardial revascularization. The first group included 170 patients after coronary artery bypass grafting (CABG), and the second group comprised of 280 patients after PCI. Results: Identified risk factors for heart failure, acute stent or shunt thrombosis, atrial fibrillations, ventricular arrhythmias, neurological complications and deathsReferences
1. Бокерия, Л. А. Сердечно-сосудистые заболевания в Российской Федерации на рубеже веков: смертность, распространенность, факторы риска / Л. А. Бокерия, И. Н. Ступаков, И. В. Самородская, Ю. М. Ботнарь // Бюллетень НЦССХ им. А. Н. Бакулева РАМН. – 2007. – № 5.2. Какучая, Т. Т. Фибрилляция предсердий после АКШ: прогностические факторы, особенности диагностики и лечения: дис. … канд. мед. наук / Т. Т. Какучая. – М., 2004.
3. Лобачева, Г. В. Факторы риска развития после- операционных осложнений после операций на открытом сердце: дис. … д-ра мед. наук / Г. В. Лобачева. – М., 2000.
4. Фарафонова, Т. Н. Нарушения ритма сердца в ранние сроки после операции коронарного шунтирования на работающем сердце: дис. … канд. мед. наук / Т. Н. Фарафонова. – М., 2006.
5. Шумков, К. В. Сочетанное немедикаментозное лечение желудочковых аритмий у больных ИБС: дис. … канд. мед. наук / К. В. Шумков. – М., 2005.
6. Barner, H. B. Operative treatment of coronary atherosclerosis / H. B. Barner // Ann. Thorac. Surg. – 2008. – Vol. 85. – P. 1473–1482.
7. Bittl, J. A. Advances in coronary angioplasty / J. A. Bittl // N. Engl. J. Med. – 1996. – Vol. 335. – P. 1290–1302.
8. Booth, J. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS) / J. Booth, T. Clayton, J. Pepper et al. // Circulation. – 2008. – Vol. 118. – P. 381–388.
9. Bravata, D. M. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery / D. M. Bravata, A. L. Gienger, K. M. McDonald et al. // Ann. Intern. Med. – 2007. – Vol. 147. – P. 703–716.
10. Brener, S. J. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients / S. J. Brener, J. M. Galla, R. Bryant III et al. // Am. J. Cardiol. – 2008. – Vol. 101. – P. 169–172.
11. Briguori, C. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus / C. Briguori, G. Condorelli, F. Airoldi et al. // Am. J. Cardiol. – 2007. – Vol. 99. – P. 779–784.
12. Buszman, P. E. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization / P. E. Buszman, S. R. Kiesz, A. Bochenek et al. // J. Am. Coll. Cardiol. – 2008. – Vol. 51. – P. 538–545.
13. Buxton, B. F. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery: risk-adjusted survival / B. F. Buxton, M. Komeda, J. A. Fuller, I. Gordon // Circulation. – 1998. – Vol. 98 (Suppl. II-1).
14. Chieffo, A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience / A. Chieffo, N. Morici, F. Maisano et al. // Circulation. – 2006. – Vol. 113. – P. 2542–2547.
15. Cohen, D. Three-year SYNTAX results extend CABG advantage to intermediate-risk patients / D. Cohen, A. P. Kappetein. – 2010 // http://www.The heart.org
16. Colombo, A. 365-day follow-up of the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloon-expandable stent / A. Colombo, J. Fajadet, G. Schuler // Eur. Heart J. – 2002. – Vol. 4. – P. 264 (Suppl. A).
17. Daemen, J. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials/ J. Daemen, E. Boersma, M. Flather et al. // Circulation. – 2008. – Vol. 118. – P. 1146–1154.
18. Fajadet, J. 210-day follow-up of the RAVEL Study: A randomized study with the sirolimus-eluting BX Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions / J. Fajadet, M. Perin, E. Hayashi // J. Am. Coll. Cardiol. – 2002. – Vol. 39. – P. 250 (Suppl. A).
19. Flynn, M. Fast-tracking revisited: routine cardiac surgical patients need minimal intensive care / M. Flynn, S. Reddy, W. Shepherd et al. // Eur. J. Cardiothorac. Surg. – 2004. – Vol. 25. – P. 116–122.
20. Grocott, H. P. Cognitive dysfunction after cardiac surgery: revisiting etiology / H. P. Grocott, H. M. Homi, F. Puskas // Semin. Cardiothorac. Vasc. Anesth. – 2005. – Vol. 9, № 2. – P. 123–129.
21. Grьntzig, A. Transluminal dilatation of coronaryartery stenosis / A. Grьntzig // Lancet. – 1978. – Vol. 1. – P. 263.
22. Hannan, E. L. Drug-eluting stents vs. coronaryartery bypass grafting in multivessel coronary disease / E. L. Hannan, C. Wu, G. Walford et al. // N. Engl. J. Med. – 2008. – Vol. 358. – P. 331–341.
23. Herz, I. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease / I. Herz, Y. Moshkovitz, D. Loberman et al. // Ann. Thorac. Surg. – 2005. – Vol. 80. – P. 2086–2090.
24. Holmes, D. R. Jr. Moses: Analysis of 1-year clinical outcomes in the SIRIUS trial / D. R. Holmes Jr, M. B. Leon // Circulation. – 2004. – Vol. 110, № 5. – P. 508–514.
25. Janssen, D. P. Preoperative prediction of prolonged stay in the intensive care unit for coronary bypass surgery / D. P. Janssen, L. Noyez, C. Wouters, R. M. Brouwer // Eur. J. Cardiothorac. Surg. – 2004. – Vol. 25. – P. 203–207.
26. Javaid, A. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease / A. Javaid, D. H. Steinberg, A. N. Buch et al. // Circulation. – 2007. – Vol. 116. – P. 200 (Suppl. 1).
27. Kaluza, G. L. Inhibition of restenosis with a paclitaxel- eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial / G. L. Kaluza, A. H. Gershlick // Am. J. Cardiol. – 2004. – Vol. 94, № 2. – P. 99–201.
28. Lagerqvist, B. Stent thrombosis in Sweden: a report from the Swedish coronary angiography and angioplasty registry / B. Lagerqvist, J. Carlsson, O. Frцbert et al. // Circ. Cardiovasc. Interv. – 2009. – Vol. 2. – P. 401–408.
29. Lee, M. S. Comparison of bypass surgery with drugeluting stents for diabetic patients with multivessel disease / M. S. Lee, F. Jamal, G. Kedia et al. // Int. J. Cardiol. – 2007. – Vol. 123. – P. 34–42.
30. Lee, M. S. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease / M. S. Lee, N. Kapoor, F. Jamal et al. // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – P. 864–870.
31. Lemos, P. A. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin – Eluting Stent Evaluation At Rotterdam Cardiology Hospital-(RESEARCH) registry / P. A. Lemos, C. H. Lee, M. Degertekin et al. // J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 2093–2099.
32. McKhann, G. M. Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction / G. M. McKhann, M. A. Grega, L. M. Borowicz Jr et al. // Arch. Neurol. – 2002. – Vol. 59, № 9. – P. 1422–1428.
33. Mora, Ch. T. The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patient undergoing coronar revascularization / Ch. T. Mora, M. B. Henson, W. S. Weintraub et al. // J. Thorac. Cardiovasc. Surg. – 1996. – Vol. 112. – P. 514–522.
34. Palmerini, T. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged >or=75 years) / T. Palmerini, F. Barlocco, A. Santarelli et al. // Eur. Heart J. – 2007. – Vol. 28. – P. 2714–2719.
35. Sanmartin, M. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease / M. Sanmartin, J. A. Baz, R. Claro et al. // Am. J. Cardiol. – 2007. – Vol. 100. – P. 970–973.
36. Schofer, J. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS) / J. Schofer, M. Schluter // Am. J. Ther. – 2004. – Vol. 11, № 3. – P. 218–228.
37. Serruys, P. W. Coronary-artery stents / P. W. Serruys, M. J. B. Kutryk, A. T. L. Ong // N. Engl. J. Med. – 2006. – Vol. 354. – P. 483–495.
38. Serruys, P. W. Percutaneous coronary intervention versus coronary artery bypass grafting for sever coronary artery disease / P. W. Serruys, M. C. Morice, A. P. Kappetein et al. // New Engl. J. Med. – 2009. – Vol. 360, № 10.
39. Serruys, P. W. Three-year follow-up of the ARTSII– sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease / P. W. Serruys, J. Daemen, M.-C. Morice et al. // EuroIntervention. – 2007. – Vol. 3. – P. 450–459.
40. Smith, S. C. Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) / S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr et al. // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – P. 216–235.
41. Stettler, C. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis / C. Stettler, S. Wandel, S. Allemann et al. // Lancet. – 2007. – Vol. 370. – P. 937–948.
42. Tavilla, G. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries / G. Tavilla, A. P. Kappetein, J. Braun et al. // Ann. Thorac. Surg. – 2004. – Vol. 77. – P. 794–799.
43. Wijns, W. ESC/EACTS Guidelines on myocardial revascularization 2010 / W. Wijns et al. // Eur. Heart J. – 2010. – Vol. 10, № 31. – P. 2501–2555.
44. Yang, Z. K. Coronary artery bypass surgery versus percutaneous coronary intervention with drugeluting stent implantation in patients with multivessel coronary disease / Z. K. Yang, W. F. Shen, R. Y. Zhang et al. // J. Interv. Cardiol. – 2007. – Vol. 20. – P. 10–16.
